Drugs for Neglected Diseases initiative 219d ago

With less than five years remaining to achieve the 2030 NTDs elimination targets—and in the context of a rapidly changing global funding landscape – it is more critical than ever to ensure that research evidence translates into actionable policy and real-world impact. The African Population and Health Research Center (APHRC) and the Drugs for Neglected Diseases initiative (DNDi) organized a webinar to explore the practical strategies for strengthening collaboration between researchers and policymakers, driving sustainable outcomes, and addressing funding challenges. Moderator: Johnstone Kotut, Policy Engagement and Advocacy Manager, African Population and Health Research Center (APHRC) Speakers: - Ngozi Erondu, Technical Director, Global Institute for Disease Elimination (GLIDE) - Samuel Kariuki, Continental Lead Africa and Eastern Africa Director, DNDi - Sultani Matendechero, Senior Deputy Director/Ag. CEO, National Quality Control Laboratories, Ministry of Health - Charles Sandy, Senior Program Officer, African Medicines Regulatory Harmonisation Programme (AMRH) - Mamadou Diallo, Head of Policy, Engagement, and Communications, African Population and Health Research Center (APHRC) ------------------ The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org